About 10 direct or indirect therapeutic core targets of ARF for RA treatment were screened through PPI network topology analyses, such as EGFR, MMP 9, IL-2, MAPK14, KDR, ACE, NOS2, ADAM17, KIT, and AKR1B1. This evidence concerns the gene CDKN2A and rheumatoid arthritis.